Cargando…

肺癌“一体化诊疗、全程管理”模式的发展现状与思考——基于四川省肿瘤医院肺癌MDT团队经验

With the improvement of medical standards, the pattern of disease diagnosis and treatment has also changed. Lung cancer is the most common malignancy and one of the most complicated diseases to diagnose and treat. Multi-disciplinary treatment (MDT) group has unique advantages in the diagnosis and tr...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210084/
https://www.ncbi.nlm.nih.gov/pubmed/32316710
http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.12
_version_ 1783531205904302080
collection PubMed
description With the improvement of medical standards, the pattern of disease diagnosis and treatment has also changed. Lung cancer is the most common malignancy and one of the most complicated diseases to diagnose and treat. Multi-disciplinary treatment (MDT) group has unique advantages in the diagnosis and treatment of tumors, but it has not been widely used in China. Therefore, it is discussed and summarized based on the diagnosis and treatment and management experience of our MDT team. The development status and promotion value of the "integrated diagnosis and treatment, full-course management" model of lung cancer are described.
format Online
Article
Text
id pubmed-7210084
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-72100842020-05-14 肺癌“一体化诊疗、全程管理”模式的发展现状与思考——基于四川省肿瘤医院肺癌MDT团队经验 Zhongguo Fei Ai Za Zhi 专家述评 With the improvement of medical standards, the pattern of disease diagnosis and treatment has also changed. Lung cancer is the most common malignancy and one of the most complicated diseases to diagnose and treat. Multi-disciplinary treatment (MDT) group has unique advantages in the diagnosis and treatment of tumors, but it has not been widely used in China. Therefore, it is discussed and summarized based on the diagnosis and treatment and management experience of our MDT team. The development status and promotion value of the "integrated diagnosis and treatment, full-course management" model of lung cancer are described. 中国肺癌杂志编辑部 2020-04-20 /pmc/articles/PMC7210084/ /pubmed/32316710 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.12 Text en 版权所有©《中国肺癌杂志》编辑部2020 This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/.
spellingShingle 专家述评
肺癌“一体化诊疗、全程管理”模式的发展现状与思考——基于四川省肿瘤医院肺癌MDT团队经验
title 肺癌“一体化诊疗、全程管理”模式的发展现状与思考——基于四川省肿瘤医院肺癌MDT团队经验
title_full 肺癌“一体化诊疗、全程管理”模式的发展现状与思考——基于四川省肿瘤医院肺癌MDT团队经验
title_fullStr 肺癌“一体化诊疗、全程管理”模式的发展现状与思考——基于四川省肿瘤医院肺癌MDT团队经验
title_full_unstemmed 肺癌“一体化诊疗、全程管理”模式的发展现状与思考——基于四川省肿瘤医院肺癌MDT团队经验
title_short 肺癌“一体化诊疗、全程管理”模式的发展现状与思考——基于四川省肿瘤医院肺癌MDT团队经验
title_sort 肺癌“一体化诊疗、全程管理”模式的发展现状与思考——基于四川省肿瘤医院肺癌mdt团队经验
topic 专家述评
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210084/
https://www.ncbi.nlm.nih.gov/pubmed/32316710
http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.12
work_keys_str_mv AT fèiáiyītǐhuàzhěnliáoquánchéngguǎnlǐmóshìdefāzhǎnxiànzhuàngyǔsīkǎojīyúsìchuānshěngzhǒngliúyīyuànfèiáimdttuánduìjīngyàn
AT fèiáiyītǐhuàzhěnliáoquánchéngguǎnlǐmóshìdefāzhǎnxiànzhuàngyǔsīkǎojīyúsìchuānshěngzhǒngliúyīyuànfèiáimdttuánduìjīngyàn